• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Albemarle Corporation (Amendment)

    2/13/24 4:58:48 PM ET
    $ALB
    Major Chemicals
    Industrials
    Get the next $ALB alert in real time by email
    SC 13G/A 1 tv0220-albemarlecorp.htm SCHEDULE 13G/A albemarlecorp

    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Schedule 13G

    Under the Securities Exchange Act of 1934
    (Amendment No.: 13)*

    Name of issuer:  Albemarle Corp

    Title of Class of Securities:  Common Stock

    CUSIP Number:  012653101

    Date of Event Which Requires Filing of this Statement: December 29, 2023

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☒ Rule 13d-1(b)

    ☐ Rule 13d-1(c)

    ☐ Rule 13d-1(d)

    *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

    (Continued on the following page(s))

     

     

    13G

    CUSIP No.:  012653101

    1.  NAME OF REPORTING PERSON
    I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

    The Vanguard Group - 23-1945930

    2.  CHECK THE APPROPRIATE [LINE] IF A MEMBER OF A GROUP

    A. 

    B.  X

    3.  SEC USE ONLY

    4.  CITIZENSHIP OF PLACE OF ORGANIZATION

    Pennsylvania

    (For questions 5-8, report the number of shares beneficially owned by each reporting person with:)

    5.  SOLE VOTING POWER

    0

    6.  SHARED VOTING POWER

    148,789

    7.  SOLE DISPOSITIVE POWER

    13,586,552

    8.  SHARED DISPOSITIVE POWER

    496,970

    9.  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    14,083,522

    10.  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

    N/A

    11.  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

    12.00%

    12.  TYPE OF REPORTING PERSON

    IA

     

     

    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Schedule 13G
    Under the Securities Act of 1934

    Item 1(a) - Name of Issuer:

    Albemarle Corp

    Item 1(b) - Address of Issuer's Principal Executive Offices:

    4250 Congress Street, Suite 900
    Charlotte, NC 28209

    Item 2(a) - Name of Person Filing:

    The Vanguard Group - 23-1945930

    Item 2(b) – Address of Principal Business Office or, if none, residence:

    100 Vanguard Blvd.
    Malvern, PA 19355

    Item 2(c) – Citizenship:

    Pennsylvania

    Item 2(d) - Title of Class of Securities:

    Common Stock

    Item 2(e) - CUSIP Number

    012653101

    Item 3 - Type of Filing:

    This statement is being filed pursuant to Rule 13d-1.  An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E).

    Item 4 - Ownership:

      (a) Amount Beneficially Owned:

      (b) Percent of Class:

     

     

    (c)  Number of shares as to which such person has:

    (i)  sole power to vote or direct to vote:  

    (ii)  shared power to vote or direct to vote:  

    (iii)  sole power to dispose of or to direct the disposition of:  

    (iv)  shared power to dispose or to direct the disposition of:  

    Comments:

    The responses to questions 5 through 9 and 11 on the cover page(s) are incorporated by reference into this Item 4.  

    Item 5 - Ownership of Five Percent or Less of a Class:

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following ☐

    Item 6 - Ownership of More Than Five Percent on Behalf of Another Person:

    The Vanguard Group, Inc.'s clients, including investment companies registered under the Investment Company Act of 1940 and other managed accounts, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities reported herein.

    No one other person's interest in the securities reported herein is more than 5%.

    Item 7 - Identification and Classification of the Subsidiary Which Acquired The Security Being Reported on by the Parent Holding Company:

    Not applicable

    Item 8 - Identification and Classification of Members of Group:

    Not applicable

    Item 9 - Notice of Dissolution of Group:

    Not applicable

    Item 10 - Certification:

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §240.14a-11.

    Signature

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Date:  February 13, 2024

    By /s/ Ashley Grim
    Name: Ashley Grim
    Title:  Head of Global Fund Administration

    Get the next $ALB alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ALB

    DatePrice TargetRatingAnalyst
    2/5/2025Outperform → In-line
    Evercore ISI
    1/28/2025$96.00Hold
    Truist
    1/14/2025$112.00Buy
    Clarksons Platou
    8/5/2024$102.00 → $85.00Outperform → Neutral
    Robert W. Baird
    7/31/2024$160.00 → $83.00Buy → Hold
    Berenberg
    7/17/2024$95.00Buy → Hold
    HSBC Securities
    7/11/2024$145.00 → $100.00Overweight → Equal Weight
    Wells Fargo
    5/22/2024$150.00 → $135.00Sector Outperform → Sector Perform
    Scotiabank
    More analyst ratings

    $ALB
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Albemarle downgraded by Evercore ISI

      Evercore ISI downgraded Albemarle from Outperform to In-line

      2/5/25 9:17:34 AM ET
      $ALB
      Major Chemicals
      Industrials
    • Truist initiated coverage on Albemarle with a new price target

      Truist initiated coverage of Albemarle with a rating of Hold and set a new price target of $96.00

      1/28/25 7:08:44 AM ET
      $ALB
      Major Chemicals
      Industrials
    • Clarksons Platou initiated coverage on Albemarle with a new price target

      Clarksons Platou initiated coverage of Albemarle with a rating of Buy and set a new price target of $112.00

      1/14/25 7:34:21 AM ET
      $ALB
      Major Chemicals
      Industrials

    $ALB
    Financials

    Live finance-specific insights

    See more
    • Albemarle Announces 126th Consecutive Quarterly Common Stock Dividend

      CHARLOTTE, N.C., May 6, 2025 /PRNewswire/ -- The Board of Directors of Albemarle Corp. (NYSE:ALB) announced today that it declared a quarterly common stock dividend of $0.405 per share. This marks Albemarle's 126th consecutive quarterly cash dividend. The dividend, which has an annualized rate of $1.62, is payable July 1, 2025, to shareholders of record at the close of business as of June 13, 2025. About AlbemarleAlbemarle Corp. (NYSE:ALB) leads the world in transforming essential resources into critical ingredients for mobility, energy, connectivity and health. We partner to

      5/6/25 4:15:00 PM ET
      $ALB
      Major Chemicals
      Industrials
    • Albemarle Reports First Quarter 2025 Results

      CHARLOTTE, N.C., April 30, 2025 /PRNewswire/ -- Albemarle Corporation (NYSE:ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced its results for the first quarter ended March 31, 2025. First-Quarter 2025 and Recent Highlights(Unless otherwise stated, all percentage changes represent year-over-year comparisons) Net sales of $1.1 billion, with double-digit volume growth in Specialties (+11%) and record Energy Storage lithium salt production from the company's integrated conversion networkNet income of $41 million, o

      4/30/25 4:15:00 PM ET
      $ALB
      Major Chemicals
      Industrials
    • Albemarle Corporation to Release First Quarter 2025 Earnings Results on Wednesday, April 30, 2025

      CHARLOTTE, N.C., April 2, 2025 /PRNewswire/ -- Albemarle Corporation (NYSE:ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, announced today that it will release its first quarter 2025 earnings after the NYSE closes on Wednesday, April 30, 2025. The company will hold a conference call to discuss its first quarter 2025 results on Thursday, May 1, at 8 a.m. ET. Access to the call is available via webcast or direct dial. A link to the webcast can be found through Albemarle Corporation's website at http://investors.albemarle.com.

      4/2/25 4:15:00 PM ET
      $ALB
      Major Chemicals
      Industrials

    $ALB
    Leadership Updates

    Live Leadership Updates

    See more
    • Ketjen Announces the Appointment of Henri Tausch as Chief Commercial Officer

      Ketjen Corporation, a leader in catalyst and specialty chemicals manufacturing, today announces the appointment of Henri Tausch to Chief Commercial Officer (CCO) effective June 24, 2024. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240619765799/en/Henri Tausch, Ketjen Chief Commercial Officer (Photo: Business Wire) In his role as Chief Commercial Officer, Tausch will oversee and advance the company's commercial strategy, and foster key partnerships to accelerate the company's global growth trajectory. "I am honored to join Ketjen and contribute to its continued success," said Henri Tausch "It's inspiring to see Ketjen's dedi

      6/19/24 7:00:00 AM ET
      $ALB
      Major Chemicals
      Industrials
    • International Paper Announces Changes to Its Board of Directors

       Jamie A. Beggs and Scott A. Tozier to Join as Newest Board Members Ilene S. Gordon to Retire from the Board MEMPHIS, Tenn., May 22, 2024 /PRNewswire/ -- International Paper ("IP") (NYSE:IP) announced that Jamie A. Beggs and Scott A. Tozier have been elected to IP's Board of Directors, effective May 21, 2024. The company also announced that Ilene S. Gordon has retired from the Board citing personal and health reasons, effective May 21, 2024. Ms. Beggs, age 47, currently serves as Senior Vice President and Chief Financial Officer of Avient Corporation (NYSE:AVNT), a premier pr

      5/23/24 10:51:00 AM ET
      $ALB
      $AVNT
      $IP
      Major Chemicals
      Industrials
      Paper
      Basic Materials
    • Albemarle Reports Net Sales Increase of 60% for Second Quarter 2023

      CHARLOTTE, N.C., Aug. 2, 2023 /PRNewswire/ -- Albemarle Corporation (NYSE:ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced its results for the second quarter ended June 30, 2023. Second-Quarter 2023 and Recent Highlights(Unless otherwise stated, all percentage changes represent year-over-year comparisons) Net sales of $2.4 billion, an increase of 60%Net income of $650.0 million, or $5.52 per diluted share, an increase of 60%Adjusted diluted EPS of $7.33, an increase of 112%Adjusted EBITDA of $1.0 billion, an i

      8/2/23 4:15:00 PM ET
      $ALB
      Major Chemicals
      Industrials

    $ALB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • VP, Corporate Controller & CAO Labauve Donald J. Jr. was granted 3,517 shares, increasing direct ownership by 66% to 8,811 units (SEC Form 4)

      4 - ALBEMARLE CORP (0000915913) (Issuer)

      3/3/25 6:27:12 PM ET
      $ALB
      Major Chemicals
      Industrials
    • Chief People Officer Anderson Melissa H. was granted 5,541 shares, increasing direct ownership by 45% to 17,893 units (SEC Form 4)

      4 - ALBEMARLE CORP (0000915913) (Issuer)

      3/3/25 6:26:47 PM ET
      $ALB
      Major Chemicals
      Industrials
    • SVP, Ext. Affairs & Comm. Lima Cynthia Renee was granted 7,599 shares, increasing direct ownership by 1,538% to 8,093 units (SEC Form 4)

      4 - ALBEMARLE CORP (0000915913) (Issuer)

      3/3/25 6:26:21 PM ET
      $ALB
      Major Chemicals
      Industrials

    $ALB
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Albemarle Announces 126th Consecutive Quarterly Common Stock Dividend

      CHARLOTTE, N.C., May 6, 2025 /PRNewswire/ -- The Board of Directors of Albemarle Corp. (NYSE:ALB) announced today that it declared a quarterly common stock dividend of $0.405 per share. This marks Albemarle's 126th consecutive quarterly cash dividend. The dividend, which has an annualized rate of $1.62, is payable July 1, 2025, to shareholders of record at the close of business as of June 13, 2025. About AlbemarleAlbemarle Corp. (NYSE:ALB) leads the world in transforming essential resources into critical ingredients for mobility, energy, connectivity and health. We partner to

      5/6/25 4:15:00 PM ET
      $ALB
      Major Chemicals
      Industrials
    • Albemarle Reports First Quarter 2025 Results

      CHARLOTTE, N.C., April 30, 2025 /PRNewswire/ -- Albemarle Corporation (NYSE:ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced its results for the first quarter ended March 31, 2025. First-Quarter 2025 and Recent Highlights(Unless otherwise stated, all percentage changes represent year-over-year comparisons) Net sales of $1.1 billion, with double-digit volume growth in Specialties (+11%) and record Energy Storage lithium salt production from the company's integrated conversion networkNet income of $41 million, o

      4/30/25 4:15:00 PM ET
      $ALB
      Major Chemicals
      Industrials
    • Albemarle Corporation to Release First Quarter 2025 Earnings Results on Wednesday, April 30, 2025

      CHARLOTTE, N.C., April 2, 2025 /PRNewswire/ -- Albemarle Corporation (NYSE:ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, announced today that it will release its first quarter 2025 earnings after the NYSE closes on Wednesday, April 30, 2025. The company will hold a conference call to discuss its first quarter 2025 results on Thursday, May 1, at 8 a.m. ET. Access to the call is available via webcast or direct dial. A link to the webcast can be found through Albemarle Corporation's website at http://investors.albemarle.com.

      4/2/25 4:15:00 PM ET
      $ALB
      Major Chemicals
      Industrials

    $ALB
    SEC Filings

    See more
    • Albemarle Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - ALBEMARLE CORP (0000915913) (Filer)

      5/9/25 4:24:16 PM ET
      $ALB
      Major Chemicals
      Industrials
    • SEC Form SCHEDULE 13G filed by Albemarle Corporation

      SCHEDULE 13G - ALBEMARLE CORP (0000915913) (Subject)

      5/9/25 1:04:11 PM ET
      $ALB
      Major Chemicals
      Industrials
    • SEC Form 10-Q filed by Albemarle Corporation

      10-Q - ALBEMARLE CORP (0000915913) (Filer)

      4/30/25 4:35:44 PM ET
      $ALB
      Major Chemicals
      Industrials

    $ALB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Albemarle Corporation

      SC 13G/A - ALBEMARLE CORP (0000915913) (Subject)

      12/5/24 7:27:01 PM ET
      $ALB
      Major Chemicals
      Industrials
    • SEC Form SC 13G filed by Albemarle Corporation

      SC 13G - ALBEMARLE CORP (0000915913) (Subject)

      11/13/24 12:52:42 PM ET
      $ALB
      Major Chemicals
      Industrials
    • Amendment: SEC Form SC 13G/A filed by Albemarle Corporation

      SC 13G/A - ALBEMARLE CORP (0000915913) (Subject)

      11/13/24 10:27:59 AM ET
      $ALB
      Major Chemicals
      Industrials

    $ALB
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Coleman Kristin M. bought $167,314 worth of shares (1,373 units at $121.86) (SEC Form 4)

      4 - ALBEMARLE CORP (0000915913) (Issuer)

      11/7/23 4:39:49 PM ET
      $ALB
      Major Chemicals
      Industrials